Vertex Pharmaceuticals Just Hit an All-Time High. Here’s Why the Biotech Stock Could Soar Even More
The past couple of years have been volatile for Vertex Pharmaceuticals (VRTX -2.07%). Between clinical setbacks and worse-than-expected financial results, […]









